REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Laboratorio Clinico Shamalab S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Ips Laboratorio Clinico Shamalab S.A.S. Profile Updated: March 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Ips Laboratorio Clinico Shamalab S.A.S. is based in Colombia. The head office is in Barranquilla. The enterprise operates in the Diagnostic Imaging Centers industry. It was first established on May 14, 2010. Ips Laboratorio Clinico Shamalab S.A.S. currently employs 2 (2026) people. The company’s latest financial report indicates a net sales revenue drop of 63.9% in 2025. In 2025, Ips Laboratorio Clinico Shamalab S.A.S.’s net profit margin decreased by 40.53%.

Headquarters
Calle 68 B No 50 - 59 Local 1
Barranquilla; Atlantico;

Contact Details: Purchase the Ips Laboratorio Clinico Shamalab S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Ips Laboratorio Clinico Shamalab S.A.S. report to view the information.
Registered Capital:
Purchase the Ips Laboratorio Clinico Shamalab S.A.S. report to view the information.
Financial Auditors:
Purchase the Ips Laboratorio Clinico Shamalab S.A.S. report to view the information.
Incorporation Date:
May 14, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Laboratorio Clinico Shamalab S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-63.9%
Total Operating Revenue
-63.9%
Net Profit/Loss for the Period
-99.85%
Total Assets
0%
Total Equity
0.07%
Net Profit Margin
-40.53%
Return on Equity (ROE)
-47.13%
Quick Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?